Skip to content

Effect of Virtual Reality Application on Pain, Anxiety and Comfort During Chest Tube Removal Procedure

Göğüs Tüpü Çıkarma İşlemi Sırasında Sanal Gerçeklik Uygulamasının Ağrı, Anksiyete ve Konfora Etkisi

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06550323
Enrollment
82
Registered
2024-08-13
Start date
2023-03-20
Completion date
2024-08-30
Last updated
2024-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Tube Removal

Keywords

virtual reality, pain, anxiety, comfort

Brief summary

Chest tubes are used to eliminate possible acute or chronic problems that may occur after trauma or surgical interventions to the chest area. This process, which aims to drain the fluid, blood or air accumulated in the pleural area, works with the support of closed underwater drainage systems. The chest tubes, which remain in place for a long time, fuse with the endothelium lying in the chest cavity. For this reason, the adhesions formed with the fusion cause very severe acute pain in the patient with the pulling force applied during removal.The high level of pain of the person will cause an increase in the level of anxiety and a decrease in the level of comfort. The anxiety experienced by the patients will also reduce the tolerance to pain.It has been observed that the use of virtual reality in the field of health significantly reduces the level of pain and anxiety during medical procedures, shortens wound healing and hospital stay, and increases compliance with treatment.In the literature, no studies were found in which the effects of virtual reality application on pain, anxiety and comfort were evaluated in patients whose chest tube was removed.Thereforee, this study was conducted to evaluate the effect of virtual reality application against all these negative situations.

Interventions

DEVICEGroup using virtual reality glasses

Group using virtual reality glasses: During the procedure, individuals will wear glasses.

Sponsors

Hale Rumeysa Seçer
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Study Inclusion Criteria: * Must be between the ages of 18-65, * Must have undergone coronary artery bypass graft surgery and have a chest tube, * Must participate in the study voluntarily, * Must not have vision or hearing problems, * Must not have disorientation in place and time, * Must not have any psychiatric disorders, * Study

Exclusion criteria

* Those with chronic pain and routinely using painkillers, * Those using painkillers before the procedure, * Those with problems such as migraine, vertigo, dizziness, * Patients using prescription glasses and those having vision problems without glasses were not included in the study.

Design outcomes

Primary

MeasureTime frameDescription
comfort scale5 monthIt is a scale ranging from 0 to 10 points. While 0 points indicate 'most comfortable', 10 points indicate 'most uncomfortable'. The minimum value is 0 and the maximum value is 10. 0 represents a good result and 10 represents a bad result
visual analog scale5 monthTo evaluate pain severity, pain results are evaluated by scoring between 0-10. While 0 indicates No pain, 10 indicates Unbearable pain. The minimum value is 0 and the maximum value is 10. 0 represents a good result and 10 represents a bad result
State-Trait Anxiety Inventory Scale5 monthIt is a 4-point Likert-type scale with 40 items and is scored as never: 1, a little: 2, a lot: 3, completely: 4, according to the degree of severity of the feelings, thoughts or behaviors expressed by the items. anxiety level will be determined.
verbal pain scale5 month0 points indicate No pain, 1 point indicates Mild pain, 2 points indicate Moderate pain and 3 points indicate Severe pain.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026